Jana Stefanickova
Overview
Explore the profile of Jana Stefanickova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamouz J, Nowosielska A, Swiech-Zubilewicz A, Abengoechea S, Baumane K, Vajas A, et al.
Ophthalmol Retina
. 2024 Oct;
PMID: 39389463
Objective: This study aimed to demonstrate the clinical equivalence of biosimilar QL1205 and reference ranibizumab, Lucentis, in patients with neovascular age-related macular degeneration (nAMD). Design: This was a multicenter, double-masked,...
2.
Kusenda P, Caprnda M, Gabrielova Z, Kukova N, Pavlovic S, Stefanickova J
Diagnostics (Basel)
. 2024 Feb;
14(4).
PMID: 38396439
Background: In patients with wet age-related macular degeneration (AMD), loss to follow-up (LTFU) leads to unplanned interruptions in therapy and the risk of visual loss. Methods: This retrospective and prospective...
3.
Singh R, Barakat M, Ip M, Wykoff C, Eichenbaum D, Joshi S, et al.
JAMA Ophthalmol
. 2023 Nov;
141(12):1152-1160.
PMID: 37971723
Importance: Despite the effectiveness of existing anti-vascular endothelial growth factor (VEGF) therapies, a need remains for further treatment options to improve response rates and/or reduce injection or monitoring frequency in...
4.
Garweg J, Stefanickova J, Hoyng C, Niesen T, Schmelter T, Leal S, et al.
Adv Ther
. 2022 Apr;
39(6):2701-2716.
PMID: 35412227
Introduction: The purpose was to compare two flexible regimens of intravitreal aflibercept (IVT-AFL) with fixed dosing every 8 weeks, beyond the first year of treatment, in patients with diabetic macular...
5.
Ankita , Saxena S, Ahmad M, Nim D, Mahdi A, Kaur A, et al.
Clin Lab
. 2022 Feb;
68(2).
PMID: 35142205
Background: The aim was to study the association of serum total calcium, ionic calcium, and magnesium with increases in macular thickness parameters and photoreceptor ellipsoid zone (EZ) disruption in diabetic...
6.
Popov I, Jurenova D, Valaskova J, Sanchez-Chicharro D, Stefanickova J, Waczulikova I, et al.
Medicina (Kaunas)
. 2021 Jul;
57(6).
PMID: 34206059
This retrospective consecutive case control study compares best-corrected visual acuity (BCVA), mesopic contrast sensitivity (CS), color vision, and glare between a group of eyes with blue-light-filtering intraocular lenses and another...
7.
Popov I, Waczulikova I, Stefanickova J, Valaskova J, Tomcikova D, Shiwani H, et al.
Eur J Ophthalmol
. 2021 Mar;
32(1):213-220.
PMID: 33653160
Objectives: To describe the pattern and mutual relationships between basic biometric characteristics of the eye in a Central European Caucasian population. Methods: A single-centre retrospective study of 2340 patients (965...
8.
Nadri G, Saxena S, Stefanickova J, Ziak P, Benacka J, Gilhotra J, et al.
J Diabetes Complications
. 2019 Jun;
33(8):550-553.
PMID: 31186163
Purpose: To study the correlation between disorganization of inner retinal layer (DRIL) and macular thickness parameters, ellipsoid zone (EZ) disruption and retinal nerve fiber layer (RNFL) thickness on spectral domain...
9.
Garweg J, Stefanickova J, Hoyng C, Schmelter T, Niesen T, Sowade O, et al.
Ophthalmol Retina
. 2019 May;
3(7):567-575.
PMID: 31080168
Purpose: To examine vision-related quality of life in patients with diabetic macular edema (DME) treated with intravitreal aflibercept (EYLEA, Regeneron Pharmaceuticals, Inc, Tarrytown, NY). Design: AQUA was a multicenter, open-label,...
10.
Ankita , Stefanickova J, Saxena S, Nim D, Ahmad K, Mahdi A, et al.
Int Ophthalmol
. 2019 Jan;
39(10):2237-2243.
PMID: 30628026
Purpose: To study the association of serum ionic calcium and glycated hemoglobin (HbA1c) with retinal photoreceptor ellipsoid zone (EZ) disruption in diabetic retinopathy (DR). Methods: This is a tertiary care...